Prevalence of and Short-term Changes in Conjunctival Manifestations Among Patients With SARS-CoV-2 Infection.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35438760.
- Also identified by DOI 10.1001/jamanetworkopen.2022.7734 and PMC identifier 9020207.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study assesses the prevalence of SARS-CoV-2–related conjunctival manifestations and conjunctival swab positivity on hospital admission and 3 days thereafter for patients not receiving anti-inflammatory treatment.
Medical subject headings
- COVID-19